Pfizer's Covid-19 vaccine is considered by healthcare authorities to be safe and effective, with data gathered from billions ...

Social mobile app connects Pfizer with the right patients in the right place! There are no other emerging digital channels that capture the tension between opportunity and challenge for ...

SpringWorks Therapeutics sprung out of Pfizer’s storeroom, when a rare disease advocacy group pushed to keep a program for neurofibromatosis alive. This method could work for “every rare disease under ...

Pfizer has emerged as a winner in the 2025 Super Bowl advertising race. The company’s “Knock You Out” ad took first place among all commercials, scoring 19% above the norm in likeability.

Pfizer appoints former J&J executive to lead obesity drug development Pfizer on Thursday named James List as the head of the drugmaker's Internal Medicine portfolio, where he will oversee the ...

Pfizer generated strong growth last year despite a significant drop in COVID revenue. The company's business is solid, and its growth prospects are encouraging. Investors, however, remain ...

Pfizer's vaccine for Clostridium difficile ... diff infection (CDI) as a result of social isolation caused by the COVID-19 pandemic, and to highlight secondary endpoints in the trial that it ...

Cavazzoni previously worked at Pfizer prior to joining the FDA in 2018 ... Kennedy posted on social media that FDA employees who are “part of this corrupt system” should “pack their bags.” ...

Claims on social media suggest Pfizer's COVID vaccine has fatal side effects, referencing a US House document. However, the report includes adverse events, not side effects. Adverse events ...

After an apparent accidental early release, Pfizer has revealed phase 1 data showing its investigational candidate, alongside Xtandi, reduced prostate cancer progression by 49%. The data ...

Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. The New York pharma is ending global development and commercialization of ...